Back to search

Protection of innate immunity by C5aR antagonist in septic mice

Data up to Jan 2025

Published2002
Citations166
References55

Total Citations Per Year

Abstract

References (55)

Sepsis and septic shock—A review of laboratory models and a proposal

1980 • 1,441 citations

The chemotactic receptor for human C5a anaphylatoxin

1991 • 660 citations

ANIMAL MODELS OF SEPSIS AND SHOCK

1998 • 577 citations

Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

1978 • 512 citations

Protective effects of C5a blockade in sepsis

1999 • 403 citations

The Neutrophil: Function and Regulation in Innate and Humoral Immunity

2001 • 304 citations

Role of Resident Peritoneal Macrophages and Mast Cells in Chemokine Production and Neutrophil Migration in Acute Inflammation: Evidence for an Inhibitory Loop Involving Endogenous IL-10

1999 • 300 citations

Update on the Mechanisms of Immune Suppression of Injury and Immune Modulation

1996 • 297 citations

Impaired mast cell-dependent natural immunity in complement C3-deficient mice

1997 • 283 citations

Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a

1999 • 245 citations

Role of C5a in Multiorgan Failure During Sepsis

2001 • 216 citations

Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma

2001 • 205 citations

Requirement and role of C5a in acute lung inflammatory injury in rats.

1996 • 196 citations

Impaired Inflammatory Responses in the Reverse Arthus Reaction Through Genetic Deletion of the C5a Receptor

1997 • 191 citations

Cutting Edge: Targeted Disruption of the C3a Receptor Gene Demonstrates a Novel Protective Anti-Inflammatory Role for C3a in Endotoxin-Shock

2000 • 187 citations

Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.

1995 • 182 citations

Complement factors and their receptors

1997 • 160 citations

Development of C5a receptor antagonists. Differential loss of functional responses.

1994 • 152 citations

Innate immunity and autoimmunity: from self-protection to self-destruction

2001 • 149 citations

Selection of a C5a Receptor Antagonist from Phage Libraries Attenuating the Inflammatory Response in Immune Complex Disease and Ischemia/Reperfusion Injury

1999 • 144 citations

Protective effects of anti‐C5a peptide antibodies in experimental sepsis

2001 • 135 citations

Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.

1981 • 129 citations

Circulating complement proteins in multiple trauma patients-Correlation with injury severity, development of sepsis, and outcome

1997 • 129 citations

POSTINJURY NEUTROPHIL PRIMING AND ACTIVATION STATES

1995 • 115 citations

Pathophysiologic basis of sepsis: Considerations for future strategies of intervention

2000 • 108 citations

A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats

2000 • 107 citations

Pivotal Role of Signal Transducer and Activator of Transcription (Stat)4 and Stat6 in the Innate Immune Response during Sepsis

2001 • 106 citations

A Role for CD21/CD35 and CD19 in Responses to Acute Septic Peritonitis: A Potential Mechanism for Mast Cell Activation

2000 • 95 citations

Expression of the anaphylatoxin C5a receptor in non-myeloid cells

1999 • 94 citations

Small Molecular Probes for G-Protein-Coupled C5a Receptors: Conformationally Constrained Antagonists Derived from the C Terminus of the Human Plasma Protein C5a

1998 • 84 citations

Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor.

1992 • 75 citations

Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration

1999 • 74 citations

S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a.

1998 • 72 citations

Effects of a new C5a receptor antagonist on C5a‐ and endotoxin‐ induced neutropenia in the rat

1999 • 70 citations

Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock

1993 • 63 citations

Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo

1998 • 61 citations

Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function.

1994 • 56 citations

Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization

2000 • 49 citations

The pulmonary response of C5 sufficient and deficient mice to immune complexes.

1981 • 46 citations

Development of C5a receptor antagonists.

1999 • 39 citations

Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury.

1996 • 37 citations

Response‐selective C5a agonists: differential effects on neutropenia and hypotension in the rat

1999 • 36 citations

Chemokine Regulation of Neutrophil Function in Surgical Inflammation

1999 • 34 citations

Synthetic C5a receptor agonists

1993 • 30 citations

[10] Iodination of chemokines for use in receptor binding analysis

1997 • 29 citations

Quantitative analysis of polymorphonuclear leukocyte superoxide anion generation in critically ill children

1985 • 23 citations

Two chemotactic factors, C5a and MIP-1α, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1α has a protective role

1996 • 22 citations

C5a receptor antagonists.

1999 • 21 citations

Effects of Short Heat Exposure on Human Red and White Blood Cells

1998 • 19 citations

CSa Receptor Antagonists

1999 • 16 citations

Effects of L-156,602, a C5a Receptor Antagonist, on Mouse Experimental Models of Inflammation

1992 • 13 citations

IMPAIRED BACTERIAL CLEARANCE AFTER ACTIVATION OF THE COMPLEMENT AND COAGULATION SYSTEMS

1997 • 13 citations

A simple general method for (radio)iodination of a phenylalanine residue in peptides: preparation of [cyclic][D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin, a peptide with extraordinary selectivity for .delta.-opioid receptors

1991 • 12 citations

Antagonistic peptides against human anaphylatoxin C5a.

1995 • 12 citations

Complement activation and neutrophil dysfunction in burned patients with sepsis —A study of two cases—

1989 • 4 citations

Cited By (0)

No citing papers found in database

Protection of innate immunity by C5aR antagonist in septic mice (2002) – The FASEB Journal | Metascience Observatory Explorer